While autoantibodies have been investigated for over 50 years, recent studies have provided an exciting perspective on the mechanisms of autoantibody production and the power of new technologies to identify novel autoantibody targets to elucidate aetiology and underpin patient evaluation.
[Annals Of The Rheumatic Diseases]